THE catheptic enzymes, which are concerned with proteolysis in animal tissue, undergo activation when treated with certain substances, such as HCN or H2S. These characteristic activation phenomena became of increased physiological interest with the discovery of the occurrence in tissues of natural activators, as for example, zookinase [Waldschmidt-Leitz et al., 1930], which has been shown by Waldschmidt-Leitz and Purr [1931] to be identical with reduced glutathione. The same activator has been described by Grassmann et al. [1931] for the plant proteases (papain, bromelin and yeast-proteinase). In later experiments it was established [Waldschmidt-Leitz, Scharikova and Schiiffner, 1933] that arginase, another enzyme concerned with intermediary protein metabolism, is also activated directly by metal complexes of SH compounds, for example, by reduced glutathione and ferrous or cuprous ions.
between arginase activation and the oxidation-reduction potential, for the establishment of which oxygen [Waldschmidt-Leitz, McDonald et al., 1933] or hydrogen [Edlbacher et al., 1933 ] is necessary, is in harmony with the experimental findings and accounts for the activations observed with the abovementioned compounds.
Investigations reported by various writers during the past year have shown that in general these oxidations and reductions are regulated by reversible redox systems, which in the presence of available oxygen or hydrogen show variable potentials. Of significance to the investigation is the fact that the potential is determined not by the total amount of the system present but only by the ratio of the reduced to the oxidised phase. The total amount acts to a certain extent however as a buffer. With a constant ratio of reduced form to oxidised form, it is apparent that the redox potentials will vary also with the PH. With increasing alkalinity they become more negative (more intense), and with increasing acidity, less negative (less intense). The particular physiological significance of such biological oxidations and reductions is dependent on the one hand on the assumption of a capacity to absorb such reduction potential (specificity) and on the other hand on the intensity of such potential. It will thus be necessary, in enzyme activations, to distinguish between a specificity factor, and an intensity (activation) factor, which latter is known to be influenced by PH and is responsible for the attainment of the full activity of enzymes. *-Cysieine.
----Bivalent iron.
*-Ascorbic acid-iron (Fe=).
From the curves (Fig. 1) which represent the experiments with Fe=, cysteine, cysteine-Fe= and ascorbic acid-Fe=, it is clear that the optimum development of the intensity factors of arginase, which is the development of the full activity, is dependent, as previously mentioned, on the PHE. Thus one obtains, by shifting the PlE to the alkaline side, the same activation intensity optimum as is obtained at neutral reaction by the addition of bivalent iron. WThile cysteine in acid medium is indifferent or even inbibiting, bivalent iron shows, to a less extent, the opposite picture. Bivalent iron therefore acts In a certain sense as a PR buffer with respect to the development of the specific intensity potential which is required by the arginase, and it may also act in the same way in the organism. With ascorbic acid-Fe=, the activation intensity optimum is shifted still more to the acid side than is the case with cysteine-Fe=. In agreement with these results, Hill and Mfichaelis [1933] have found that the potential developed in the system alloxantin-Fe= is also dependent on the PHEl, the bivalent iron apparently being a determinir factor.
In a previous communication . [Purr, 1933] an activation of arginase by ascorbic acid-Fe= was reported. In connection with this finding, the question was raised as to what exrtent other intermediary metabolic products exrert a regulating effect on intracellular enzymic syntheses or hvdrolvses. The experiments here reported, which have been carried through from this point of view, have shown that the activation mechanism of 'this enzyme is probably connected with a specific oxidation-reduction potential, and is not due simply to a specific effect of the SH group.
EXPERIMENTAL. The activation of arginase. The organs studied were rat liver and transplantable rat sarcoma, Philadelphia # 11. Immediately after extirpation these tissues were cut up with scissors and frozen by dipping into liquid nitrogen, then pulverised by crushing with a hammer. This finely crushed material was suspended as follows: cancer (Philadelphia # 1 rat sarcoma) in 90 % glycerol (1: 10); rat liver in 90 % glycerol (1:10); glycerol extract from liver acetone-ether dry preparation Table I . The effect of alloxan, allantoin, alloxantin and uric acid. (1: 10). The amounts used were: 5-0 ml. cancer suspension; 0-25 ml. liver suspension; 0-5 ml. extract of acetone-ether dry preparation. For activation 2-0 ml. neutral cysteine-HCl solution (containing 20 mg. cysteine-HCl) or 0-5 ml. 0-1 N FeSO4, respectively, were added to the enzyme and allowed to stand 1 hour at PH 7 at 30°. 10 ml. of 1 % arginine carbonate and 5-0 ml. 0-1 M glycine buffer of PH 9-5 were then added and the reaction mixtures allowed to stand 60 minutes at 300. Results are shown in ml. 0-02 N H2S04, as is customary. Table III . The effect of thiotacetic acid.
The enzyme was activated by 0-5 ml. 0-1 N FeSO4 or 20-0 mg. thiolacetic acid, respectively. PH 7.
Activator system Initial activity Fe= Cysteine Cysteine-Fe= Thiolacetic acid Thiolacetic acid-FeEnzyme. Cancer suspension (Philadelphia #1 rat sarcoma) (ml. 0-02 N H2SO4) 6-0 10-5 8-1 14-5 6-8 12-5 Table IV . The effect of bivalent iron in complex combination.
(Potassium ferrocyanide, Fe=-dimethylglyoxime and ocn'-dipyridylL.)
The enzyme was activated by 20-0 mg. potassium ferrocyanide; 20-0 mg. dimethylglyoxime; 5 mg. dipyridyl; (A) after 1 hour's standing with dipyridyl, FeSO4 was added and the mixture allowed to stand another hour, pH 7; (B) the same with cysteine instead of FeSO4; (C) the same with cysteine-Fe=; (D) after 1 hour's standing with dipyridyl, and another after addition of FeSO4, cysteine-Fe= was added and the mixture allowed to stand an additional hour. The enzyme was activated by 0*5 ml. 0.1 N FeSO4 or by 20 mg. cysteine-HCI or 16 mg. ascorbic acid ("chinoin") respectively, and allowed to stand 1 hour at PH 5 0, 5 5, 6-2, 7.0, 8-7, 9 5 at 300 (the PH was controlled). The activation of arginase was determined as usual at PH 9-5. It has been shown that various intermediate products of metabolism, in combination with ferrous iron, are able to activate arginase. The activation mechanism of this enzyme is probably connected with a specific oxidationreduction potential and is not due simply to a specific effect of the SH group.
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